The transcription factors NF-κB and HIF-1α are frequently activated in tumors, involved in tumor growth and progression, and resistant to chemotherapy through their ability to up-regulate the expression of tumor-promoting cytokines and survival genes. This evidence concerns the gene NFKB1 and neoplasm.